US Stock MarketDetailed Quotes

AMPL Amplitude

Watchlist
  • 10.890
  • +0.190+1.78%
Close Jan 3 16:00 ET
  • 10.850
  • -0.040-0.37%
Post 20:01 ET
1.39BMarket Cap-16.75P/E (TTM)

Amplitude Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amplitude Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
74.12M
75.22M
+1.09M
Beat Est.
+4.94%
+6.48%
+1.47%
EPS
-0.18
-0.14
+0.04
Beat Est.
-22.48%
+6.67%
+23.75%
Analyst Rating
Hold

Dec 31, 2024

Amplitude Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 77.717M--
--2024/Q4-- / 76.682M--
Nov 7, 20242024/Q375.217M / 74.124M--
Aug 8, 20242024/Q273.300M / 71.993M--
May 9, 20242024/Q172.624M / 72.253M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 77.717M--
--2024/Q4-- / 76.682M--
Nov 7, 20242024/Q375.217M / 74.124M--
Aug 8, 20242024/Q273.300M / 71.993M--
May 9, 20242024/Q172.624M / 72.253M--

Unlock Free Earnings Estimates

Amplitude Earnings Reports

  • Amplitude | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:19 ET

  • Amplitude | 8-K: Amplitude Announces Third Quarter 2024 Financial Results

    Nov 7, 2024 16:08 ET

  • Amplitude | 8-K: Amplitude Announces Second Quarter 2024 Financial Results

    Aug 8, 2024 16:55 ET

  • Amplitude | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:15 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Hold

    • Buy

      14.29%

    • Hold

      71.43%

    • Sell

      14.29%

    Price Target

    No Data